Cargando…
New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity
Proteoliposomes purified from the Outer Membrane of Neisseria meningitidis B, have been successfully used as core for adjuvants and vaccine formulations. We have tried to increase their structural definition and to conserve their efficacy and stability avoiding the addition of the aluminum hydroxide...
Autores principales: | Tamargo, Beatriz, Márquez, Yanet, Ramírez, Wendy, Cedré, Bárbara, Fresno, Manuel, Sierra, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582453/ https://www.ncbi.nlm.nih.gov/pubmed/23458443 http://dx.doi.org/10.1186/1471-2172-14-S1-S12 |
Ejemplares similares
-
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B
por: Zayas, Caridad, et al.
Publicado: (2013) -
A proteoliposome formulation derived from Bordetella pertussis induces protection in two murine challenge models
por: Fernández, Sonsire, et al.
Publicado: (2013) -
STANDARDIZATION OF ANTIMENINGOCOCCIC SERUM
por: Amoss, Harold L., et al.
Publicado: (1918) -
106 Neisseria Meningitidis Derived Proteoliposome as an Adjuvant for Allergen Vaccines
por: González, Wendy Ramírez, et al.
Publicado: (2012) -
SIMPLIFIED PRODUCTION OF ANTIMENINGOCOCCIC SERUM
por: Amoss, Harold L., et al.
Publicado: (1920)